<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00142597</url>
  </required_header>
  <id_info>
    <org_study_id>K01AT001111-01</org_study_id>
    <secondary_id>K01AT001111-01</secondary_id>
    <secondary_id>1K01AT001111-01</secondary_id>
    <nct_id>NCT00142597</nct_id>
  </id_info>
  <brief_title>Effectiveness of Acupuncture in Relieving Pain Due to Fibromyalgia</brief_title>
  <official_title>Mechanisms of Acupuncture Analgesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Complementary and Integrative Health (NCCIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Michigan</source>
  <brief_summary>
    <textblock>
      This study will determine the effectiveness of acupuncture versus a placebo in altering brain
      activity and relieving pain due to fibromyalgia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Fibromyalgia is one of the most common rheumatic diseases, second only to osteoarthritis. It
      causes chronic muscle pain and fatigue. Acupuncture functions by targeting specific nerve
      pathways to different organs or parts of the body. Research has shown that acupuncture is
      effective in decreasing or eliminating people's sensitivity to pain in targeted regions.
      However, some believe that the reduction in pain is due to a placebo response rather than
      acupuncture itself. This study will use two brain-imaging techniques to determine the brain
      response to acupuncture versus a simulation of acupuncture, thereby assessing whether
      acupuncture is actually effective in relieving pain.

      Participants in this single-blind study will be randomly assigned to receive either
      acupuncture or a placebo treatment. The placebo will consist of a simulation of acupuncture.
      Functional magnetic resonance imaging (fMRI) and positron emission tomography (PET) will be
      used to assess activity of brain mu-opioid receptors. These receptors are involved in the
      body's ability to perceive pain. All participants will be scanned twice using the fMRI
      scanner, once before any treatment sessions and once at the conclusion of all treatment
      sessions. Both fMRI sessions will involve applying pressure to the thumb to elicit a response
      in the brain in order to assess the corresponding fMRI blood oxygen level dependent (BOLD)
      signal and whether this activation changes after treatment intervention. Participants will
      then receive nine treatments of acupuncture or placebo outside the scanner over a 4-week
      period. The PET portion of this study is optional, and, if you elect to participate, your
      first treatment session will be performed in the PET scanner. After this first session,
      participants will have seven additional treatment sessions outside of the scanner over a
      4-week period. The last session will be performed in the PET scanner to assess changes in
      mu-opioid receptor activity that may have occurred over the 4 weeks. A baseline visit to
      determine eligibility and a close-out visit at week 8 are also part of the participation
      schedule. It is very important that participants live within driving distance of Ann Arbor,
      MI due to the significant number of visits to our Center.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2005</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Mu-opioid Receptor Occupancy</measure>
    <time_frame>measured from baseline to week 5</time_frame>
    <description>Here we report the change (post - pre) in mu-opioid receptor binding potential (BP) for the perigenual anterior cingulate. BP is a unitless measure and reflects the total maximum binding of receptors divided by the dissociation constant. BP = Bmax/Kd.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">46</enrollment>
  <condition>Fibromyalgia</condition>
  <arm_group>
    <arm_group_label>Traditional Acupuncture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Acupuncture sites will be used for active intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Treatment</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham acupuncture is used.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Acupuncture</intervention_name>
    <description>Involves the insertion and manual stimulation of thin acupuncture needles into specific points in the body.
Fibromyalgia participants will be randomized to receive 9 acupuncture treatments over the course of four weeks.
All participants will be scanned twice using the fMRI scanner. The PET portion of the study is optional.</description>
    <arm_group_label>Traditional Acupuncture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sham treatment</intervention_name>
    <description>Fibromyalgia participants will be randomized to receive 9 sham treatments over the course of four weeks.
All participants will be scanned twice using the fMRI scanner. The PET portion of the study is optional.</description>
    <arm_group_label>Sham Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        fMRI Inclusion Criteria:

          -  Has met American College of Rheumatology (1990) criteria for the diagnosis of
             fibromyalgia for at least 1 year

          -  Chronic pain more than 50% of days

          -  Willing to limit introduction of any new medications or treatments for fibromyalgia
             during the study

          -  Able to attend study visits up to three times weekly

          -  Right-handed

          -  Must be within driving distance of Ann Arbor, MI

        PET Inclusion Criteria:

          -  Meets fMRI inclusion criteria

          -  Willing to refrain from alcohol intake for 48 hours prior to PET studies

        Exclusion Criteria:

        fMRI Exclusion Criteria:

          -  Knowledge that could prevent &quot;blinding&quot; of the participant to the study interventions
             (including previous acupuncture treatment)

          -  Presence of a known coagulation abnormality, thrombocytopenia, or bleeding diathesis
             that may preclude the safe use of acupuncture

          -  Autoimmune or inflammatory disease (in addition to fibromyalgia) that causes pain
             (e.g., rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease)

          -  Daily use of narcotic pain-relievers

          -  History of substance abuse

          -  Simultaneous participation in other therapeutic trials

          -  Pregnant or breastfeeding

          -  Current severe psychiatric illness (e.g., schizophrenia, major depression with
             suicidal ideation)

          -  Condition that may make exposure to fMRI medically inadvisable

          -  Any condition that may prevent satisfactory completion of the study protocol

        PET Exclusion Criteria:

          -  Meets any of the fMRI exclusion criteria

          -  Current major depression

          -  Condition that may make exposure to PET medically inadvisable
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard E. Harris, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 1, 2005</study_first_submitted>
  <study_first_submitted_qc>September 1, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 2, 2005</study_first_posted>
  <results_first_submitted>December 4, 2014</results_first_submitted>
  <results_first_submitted_qc>April 9, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 13, 2015</results_first_posted>
  <last_update_submitted>April 9, 2015</last_update_submitted>
  <last_update_submitted_qc>April 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 13, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Richard Harris</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>acupuncture</keyword>
  <keyword>analgesia</keyword>
  <keyword>pain</keyword>
  <keyword>fibromyalgia</keyword>
  <keyword>fMRI</keyword>
  <keyword>PET</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Traditional Acupuncture</title>
          <description>Acupuncture sites will be used for active intervention.
Acupuncture: Involves the insertion and manual stimulation of thin acupuncture needles into specific points in the body.
Fibromyalgia participants will be randomized to receive 9 acupuncture treatments over the course of four weeks.
All participants will be scanned twice using the fMRI scanner. The PET portion of the study is optional.</description>
        </group>
        <group group_id="P2">
          <title>Sham Treatment</title>
          <description>Sham acupuncture is used.
Sham treatment: Fibromyalgia participants will be randomized to receive 9 sham treatments over the course of four weeks.
All participants will be scanned twice using the fMRI scanner. The PET portion of the study is optional.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="23">N=10 underwent PET imaging</participants>
                <participants group_id="P2" count="23">N=10 underwent PET imaging</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20">N=10 completed PET imaging</participants>
                <participants group_id="P2" count="22">N=10 completed PET imaging</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Traditional Acupuncture</title>
          <description>Acupuncture sites will be used for active intervention.
Acupuncture: Involves the insertion and manual stimulation of thin acupuncture needles into specific points in the body.
Fibromyalgia participants will be randomized to receive 9 acupuncture treatments over the course of four weeks.
All participants will be scanned twice using the fMRI scanner. The PET portion of the study is optional.</description>
        </group>
        <group group_id="B2">
          <title>Sham Treatment</title>
          <description>Sham acupuncture is used.
Sham treatment: Fibromyalgia participants will be randomized to receive 9 sham treatments over the course of four weeks.
All participants will be scanned twice using the fMRI scanner. The PET portion of the study is optional.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="23"/>
            <count group_id="B2" value="23"/>
            <count group_id="B3" value="46"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48.52" spread="12.85"/>
                    <measurement group_id="B2" value="44.87" spread="15.03"/>
                    <measurement group_id="B3" value="46.70" spread="13.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Mu-opioid Receptor Occupancy</title>
        <description>Here we report the change (post - pre) in mu-opioid receptor binding potential (BP) for the perigenual anterior cingulate. BP is a unitless measure and reflects the total maximum binding of receptors divided by the dissociation constant. BP = Bmax/Kd.</description>
        <time_frame>measured from baseline to week 5</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Traditional Acupuncture</title>
            <description>Acupuncture sites will be used for active intervention.
Acupuncture: Involves the insertion and manual stimulation of thin acupuncture needles into specific points in the body.
Fibromyalgia participants will be randomized to receive 9 acupuncture treatments over the course of four weeks.
All participants will be scanned twice using the fMRI scanner. The PET portion of the study is optional.</description>
          </group>
          <group group_id="O2">
            <title>Sham Treatment</title>
            <description>Sham acupuncture is used.
Sham treatment: Fibromyalgia participants will be randomized to receive 9 sham treatments over the course of four weeks.
All participants will be scanned twice using the fMRI scanner. The PET portion of the study is optional.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Mu-opioid Receptor Occupancy</title>
          <description>Here we report the change (post - pre) in mu-opioid receptor binding potential (BP) for the perigenual anterior cingulate. BP is a unitless measure and reflects the total maximum binding of receptors divided by the dissociation constant. BP = Bmax/Kd.</description>
          <units>Unitless: binding potential is Bmax/Kd</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2352" spread="0.1911"/>
                    <measurement group_id="O2" value=".0015" spread=".1197"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Traditional Acupuncture</title>
          <description>Acupuncture sites will be used for active intervention.
Acupuncture: Involves the insertion and manual stimulation of thin acupuncture needles into specific points in the body.
Fibromyalgia participants will be randomized to receive 9 acupuncture treatments over the course of four weeks.
All participants will be scanned twice using the fMRI scanner. The PET portion of the study is optional.</description>
        </group>
        <group group_id="E2">
          <title>Sham Treatment</title>
          <description>Sham acupuncture is used.
Sham treatment: Fibromyalgia participants will be randomized to receive 9 sham treatments over the course of four weeks.
All participants will be scanned twice using the fMRI scanner. The PET portion of the study is optional.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Richard E. Harris</name_or_title>
      <organization>University of Michigan</organization>
      <phone>734-998-6996</phone>
      <email>reharris@med.umich.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

